# CorVad Myocardial Infarction Complicated with Cardiogenic Shock Trial

Study · id `cardio:ct-nct06886113` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06886113](<https://clinicaltrials.gov/study/NCT06886113>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06886113

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 269 participants.

## Technical summary

Registry record NCT06886113. Randomized; no masking; primary purpose treatment. Start 2025-10-01 (anticipated); primary completion 2026-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 269 participants (planned count; ClinicalTrials.gov record NCT06886113, source copy `cardio:ctgov-nct06886113-2025-03-20`, retrieved 2026-10-31)
- Planned start: 2025-10-01 (anticipated) (ClinicalTrials.gov record NCT06886113, source copy `cardio:ctgov-nct06886113-2025-03-20`, retrieved 2026-10-31)
- Primary completion: 2026-08-31 (anticipated) (ClinicalTrials.gov record NCT06886113, source copy `cardio:ctgov-nct06886113-2025-03-20`, retrieved 2026-10-31)
- Completion: 2028-02-15 (anticipated) (ClinicalTrials.gov record NCT06886113, source copy `cardio:ctgov-nct06886113-2025-03-20`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT06886113, source copy `cardio:ctgov-nct06886113-2025-03-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06886113-2025-03-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: CorVad Myocardial Infarction Complicated with Cardiogenic Shock Trial
- Acronym: Corvad AMICS
- Condition: Cardiogenic Shock
- Intervention (Device): Conventional circulatory support
- Intervention (Device): CorVad
- Lead sponsor: Shenzhen Core Medical Technology CO.,LTD.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Cardiogenic shock (`cardio:cardiogenic-shock`)

## Provenance

Content hash: b267001ede6a9c3c64422b20a2629998506f6393fa28b0df5093d28de4d24eff
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
